Mart xed n Rivada x, Guerra Cantera S, Campillo Calatayud A, Andr xe9 s Esteban E, S xe1 nchez Holgado M, Martos Moreno G, et al. Pappalysins and Stanniocalcins and Their Relationship With the Peripheral IGF Axis in Newborns and During Development. J Clin Endocrinol Metab. 2022;107:2912-2924 pubmed publisher

Panagiotou G, Ghaly W, Upadhyay J, Pazaitou Panayiotou K, Mantzoros C. Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. J Clin Endocrinol Metab. 2021;106:e2137-e2150 pubmed publisher

Hjortebjerg R, Rasmussen L, Gude M, Irmukhamedov A, Riber L, Frystyk J, et al. Local IGF Bioactivity Associates with High PAPP-A Activity in the Pericardial Cavity of Cardiovascular Disease Patients. J Clin Endocrinol Metab. 2020;105: pubmed publisher

Frystyk J, Teran E, Gude M, Bjerre M, Hjortebjerg R. Pregnancy-associated plasma proteins and Stanniocalcin-2 - Novel players controlling IGF-I physiology. Growth Horm IGF Res. 2020;53-54:101330 pubmed publisher

Hjortebjerg R, Thomsen K, Agnholt J, Frystyk J. The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis. BMC Gastroenterol. 2019;19:83 pubmed publisher

Cediel G, Rueda F, Oxvig C, Oliveras T, Labata C, de Diego O, et al. Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction. Cardiovasc Diabetol. 2018;17:63 pubmed publisher